Biogen (NASDAQ: BIIB) is gaining 5% intra-day after the CEO hinted that the company is considering strategic options, but did ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE